The cardiac drug, Crestor, is said to be one of the biggest launches for USFDA this year and the market size for the drug is about USD 3 billion, reports Ekta Batra of CNBC-TV18. The drug goes off patent tomorrow in the US.
first published: Jul 8, 2016 11:53 am
A collection of the most-viewed Moneycontrol videos.
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan
Can Nifty Claw Back Above 25,600 Or Will Sensex Expiry Cap The Upside?| Opening Bell Live
Gold ETFs vs Silver ETFs | Which One Is Your Wealth Buddy?
